Neuroscience

New study sheds light on basic biology of frontotemporal dementia

Dementia encompasses a range of neurodegenerative conditions that lead to memory loss and cognitive deficiencies and affect some 55 million people worldwide. Yet despite its prevalence, there are few effective treatments, ...

Neuroscience

New study expands range of potential Alzheimer's drugs

Alzheimer's disease is associated with a reduction of insulin receptors in brain microvessels, which may contribute to brain insulin resistance and the formation of amyloid plaques, one of the disease's hallmarks. That's ...

Medications

Alzheimer's drug trial shows 'evidence of sustained improvement'

Almost four decades ago the University of Aberdeen's Chair in Mental Health (Clinical), Professor Claude Wischik, made a breakthrough in discovering that the neurofibrillary "tangles" associated with Alzheimer's disease were ...

page 30 from 40